Home › Stocks › RYTM › All Fund Holders
RYTM — RHYTHM PHARMACEUTICALS INC · All Fund Holders
Funds holding (latest): 42 · Reported value held: $3.44B
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| BlackRock Inc history | Q2 2026 | 6.16M | $683.60M | 0.01% | Reduce |
| Vanguard Group history | Q4 2025 | 6.21M | $664.82M | 0.01% | Add |
| JPMorgan Chase & Co history | Q2 2026 | 2.65M | $292.18M | 0.03% | New |
| Goldman Sachs Group history | Q2 2026 | 2.13M | $236.11M | 0.02% | Add |
| Geode Capital Management history | Q2 2026 | 1.53M | $170.32M | 0.01% | Add |
| Capital Research Global Investors history | Q2 2026 | 1.53M | $170.13M | 0.03% | Add |
| Citadel Advisors history | Q2 2026 | 1.31M | $145.36M | 0.02% | Reduce |
| Morgan Stanley history | Q2 2026 | 1.11M | $123.49M | 0.01% | Add |
| Fidelity Management & Research (FMR) history | Q2 2026 | 1.03M | $113.90M | 0.01% | Reduce |
| Alkeon Capital Management history | Q3 2025 | 1.02M | $102.78M | 0.15% | Hold |
| Janus Henderson Group history | Q1 2026 | 918.15K | $79.89M | 0.04% | Reduce |
| Norges Bank Investment Management history | Q2 2026 | 685.84K | $76.15M | 0.01% | Add |
| Franklin Resources history | Q2 2026 | 577.03K | $64.07M | 0.01% | Reduce |
| Charles Schwab Investment Management history | Q2 2026 | 552.74K | $61.37M | 0.01% | Add |
| Invesco Ltd history | Q2 2026 | 543.27K | $60.32M | 0.01% | Add |
| Northern Trust Corp history | Q2 2026 | 540.33K | $59.99M | 0.01% | Add |
| Wellington Management Group history | Q2 2026 | 488.75K | $54.27M | 0.01% | Add |
| Point72 Asset Management history | Q2 2026 | 414.21K | $45.99M | 0.05% | Reduce |
| BNY Mellon history | Q2 2026 | 394.04K | $43.75M | 0.01% | Add |
| Bank of America Corp history | Q2 2026 | 325.47K | $36.14M | 0.00% | Reduce |
| Millennium Management history | Q2 2026 | 316.72K | $35.17M | 0.01% | Reduce |
| Capital World Investors history | Q2 2026 | 221.45K | $24.59M | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 144.38K | $16.03M | 0.00% | Reduce |
| Deutsche Bank AG history | Q2 2026 | 115.23K | $12.79M | 0.00% | Reduce |
| Wells Fargo & Co history | Q2 2026 | 72.15K | $8.01M | 0.00% | Add |
| Prudential Financial history | Q2 2026 | 69.14K | $7.68M | 0.01% | Add |
| Renaissance Technologies history | Q2 2026 | 68.28K | $7.58M | 0.01% | Reduce |
| AQR Capital Management history | Q2 2026 | 59.21K | $6.57M | 0.00% | Hold |
| Citigroup Inc history | Q2 2026 | 58.35K | $6.48M | 0.00% | Add |
| Manulife Financial history | Q2 2026 | 57.17K | $6.35M | 0.01% | Add |
| CPP Investments history | Q2 2026 | 47.40K | $5.26M | 0.00% | New |
| Legal & General Investment Management America history | Q2 2026 | 43.91K | $4.88M | 0.00% | Reduce |
| Balyasny Asset Management history | Q1 2026 | 52.97K | $4.61M | 0.01% | Reduce |
| D. E. Shaw & Co history | Q2 2026 | 30.17K | $3.35M | 0.00% | Reduce |
| Lazard Asset Management history | Q2 2026 | 18.32K | $2.03M | 0.00% | Reduce |
| Marshall Wace history | Q2 2026 | 8.17K | $907.56K | 0.00% | Reduce |
| PNC Financial Services history | Q2 2026 | 7.66K | $850.16K | 0.00% | Add |
| Arrowstreet Capital history | Q3 2025 | 6.31K | $636.94K | 0.00% | New |
| Two Sigma Investments history | Q2 2026 | 4.60K | $510.74K | 0.00% | Add |
| Principal Global Investors history | Q2 2026 | 4.22K | $468.55K | 0.00% | Reduce |
| Amundi US history | Q2 2026 | 3.42K | $379.94K | 0.00% | Reduce |
| T. Rowe Price Associates history | Q2 2026 | 2.57M | $284.92K | 0.03% | Add |